Resistance-induced changes in triclabendazole transport in Fasciola hepatica: Ivermectin reversal effect

Journal of Parasitology

Volumn 92, Issue 6, 2006, Pages 1355-1360

  Mottier, L ^b   Alvarez, L ^b   Fairweather, I ^a   Lanusse, C ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; GLYCOPROTEIN P; IVERMECTIN; TRICLABENDAZOLE;

BIOASSAY; DRUG RESISTANCE; FLATWORM; HALOGENATED HYDROCARBON; IVERMECTIN; PROTEIN;

ARTICLE; DRUG EFFECT; DRUG METABOLISM; DRUG TRANSPORT; FASCIOLA HEPATICA; FASCIOLIASIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIPARASITIC AGENTS; BENZIMIDAZOLES; DRUG RESISTANCE; FASCIOLA HEPATICA; IVERMECTIN; SHEEP; SULFOXIDES;

FASCIOLA HEPATICA;

EID: 33846947190     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-922R.1     Document Type: Article

References (43)

1. ALVAREZ, L., L. MOTTIER, AND C. LANUSSE. 2004. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: Effect of bile in the incubation medium. Parasitology 128: 73-81.
2. _, H. SOLANA, L. MOTTIER, G. VIRKEL, I. FAIRWEATHER, AND C. LANUSSE. 2005. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 131: 501-510.
3. AMERICAN VETERINARY MEDICAL ASSOCIATION. 2001. Report of the AVMA panel on euthanasia. Journal of the American Veterinary Medical Association 218: 669-696.
4. BEUGNET, F., M. GAUTHEY, AND D. KERBOEUF. 1997. Partial in vitro reversal of benzimidazole resistance by the free-living stages of Haemonchus contortus with verapamil. The Veterinary Record 141: 575-576.
5. BORAY, J. 1994. Diseases of domestic animals caused by flukes. Food and Agricultural Organization of the United Nations, Rome, Italy, 49 p.
6. _, P. CROWFOOT, M. STRONG, J. ALLISON, M. SCHELLENBAUM, M. VON ORELLI, AND G. SARASIN. 1983. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. The Veterinary Record 113: 315-317.
7. BOSCH, I., Z. WANG, L. TAO, AND C. SCHOEMAKER. 1994. Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins. Molecular and Biochemical Parasitology 65: 351-356.
8. COLES, G. 2002. Sustainable use of anthelmintics in grazing animals. The Veterinary Record 151: 16-169.
9. _, AND K. STAFFORD. 2001. Activity of oxyclozanide, notroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. The Veterinary Record 148: 723-724.
10. DIDIER, A., AND F. LOOR. 1996. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs 7: 745-751.
11. FAIRWEATHER, I. 2005. Triclabendazole: New skills to unravel an old(ish) enigma. Journal of Helminthology 79: 227-234.
12. GERLACH, J., J. ENDICOTT, P. JURANKA, G. HENDERSON, F. SARANGI, K. DEUCHARS, AND V. LING. 1986. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggest a model for multidrug resistance. Nature 324: 485-489.
13. HENNESSY, D., E. LACEY, J. STEEL, AND R. PRICHARD. 1987. The kinetics of triclabendazole disposition in sheep. Journal of Veterinary Pharmacology and Therapeutics 10: 64-72.
14. HUANG, Y., AND R. PRICHARD. 1999. Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus. Molecular and Biochemical Parasitology 102: 273-281.
15. JONES, P., AND A. GEORGE. 2005. Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling. International Journal for Parasitology 35: 555-566.
16. KWA, M., M. OKOLI, H. SCHULZ-KEY, P. OKONGKWO, AND M. ROOS. 1998. Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus. International Journal for Parasitology 28: 1235-1240.
17. _, J. VEENSTRA, AND M. ROOS. 1994. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in β-tubulin isotype 1. Molecular and Biochemical Parasitology 63: 299-303.
18. LINCKE, C., I. THE, M. VAN GROENIGEN, AND P. BORST. 1992. The P-glycoprotein gene family of Caenorhabditis elegans. Cloning and characterization of genomic and complementary DNA sequences. Journal of Molecular Biology 228: 701-711.
19. LUBEGA, G., AND R. PRICHARD. 1991a. β-Tubulin and benzimidazole resistance in the sheep nematode Haemonchus contortus. Molecular and Biochemical Parasitology 47: 129-137.
20. _, AND _. 1991b. Specific interaction of benzimidazole anthelmintics with tubulin from developing stages of thiabendazole-susceptible and -resistant Haemonchus contortus. Biochemical Pharmacology 41: 93-101.
21. MARRINER, S., AND J. BOGAN. 1980. Pharmacokinetics of albendazole in sheep. American Journal of Veterinary Research 41: 1126-1129.
22. MCCRACKEN, R., AND K. LIPKOWITZ. 1990. Structure-activity relationships of benzothiazole and benzimidazole anthelmintics: A molecular modeling approach to in vivo drug efficacy. Journal of Parasitology 76: 853-864.
23. MCKELLAR, Q., AND F. JACKSON. 2004. Veterinary anthelmintics: Old and new. Trends in Parasitology 20: 456-461.
24. _, AND E. SCOTT. 1990. The benzimidazole anthelmintic agents-a review. Journal of Veterinary Pharmacology and Therapeutics 13: 223-247.
25. MERINO, G., A. ALVAREZ, J. PRIETO, AND R. KIM. 2002. The anthelmintic agent albendazole does not interact with P-glycoprotein. Drug Metabolism and Disposition 30: 365-369.
26. MOLENTO, M., AND R. PRICHARD. 1999. Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). Parasitology Research 85: 1007-1011.
27. MOTTIER, M. L. ALVAREZ, L. CEBALLOS, AND C. LANUSSE. 2006. Drug transport mechanisms in helminth parasites: Passive diffusion of benzimidazole anthelmintics. Experimental Parasitology 113: 49-57.
28. _, AND _, AND 2003. Quantitative chromatographic determination of several benzimidazole anthelmintic molecules in parasite material. Journal of Chromatography B 798: 117-125.
29. _, A. PIS, AND C. LANUSSE. 2003. Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: Correlation with their octanol-water partition coefficients. Experimental Parasitology 103: 1-7.
30. _, L. MORENO, L. ALVAREZ, G. VIRKEL, AND C. LANUSSE. 2004. Measurement of triclabendazole and its metabolites in liver flukes: Method development and full validation. Journal of Pharmaceutical and Biomedical Analysis 35: 991-999.
31. _, G. VIRKEL, H. SOLANA, L. ALVAREZ, J. SALLES, AND C. LANUSSE. 2004. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidised metabolites into Fasciola hepatica. Xenobiotica 34: 1043-1057.
32. NARE, B., Z. LIU, R. PRICHARD, AND E. GEORGES. 1994. Benzimidazoles, potent anti-mitotic drugs: Substrates for the p-glycoprotein transporter in multidrug-resistant cells. Biochemical Pharmacology 48: 2215-2222.
33. OUELLETTE, M. 2001. Biochemical and molecular mechanisms of drug resistance in parasites. Tropical Medicine and International Health 6: 874-882.
34. POULIOT, J., F. LHEUREUX, Z. LIU, R. PRICHARD, AND E. GEORGES. 1997. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochemical Pharmacology 53: 17-25.
35. REED, M., M. PANACCIO, R. STRUGNELL, AND T. SPITHILL. 1998. Developmental expression of a Fasciola hepatica sequence homologous to ABC transporters. International Journal for Parasitology 28: 1375-1381.
36. ROBINSON, M., J. LAWSON, A. TRUDGETT, E. HOEY, AND I. FAIRWEATHER. 2004. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitology Research 92: 205-210.
37. _, A. TRUDGETT, E. HOEY, AND I. FAIRWEATHER. 2002. Triclabendazole-resistant Fasciola hepatica: β-Tubulin and response to in vitro treatment with triclabendazole. Parasitology 124: 325-338.
38. SANGSTER, N. 1994. P-glycoproteins in nematodes. Parasitology Today 10: 319-322.
39. _, S. BARMAN, A. WEISS, S. NULF, R. KLEIN, AND T. GEARY. 1999. Haemonchus contortus: Sequence heterogeneity of internucleotide binding domains from P-glycoprotein and association with ivermectin/milbemycin resistance. Experimental Parasitology 91: 250-257.
40. SOLANA, H., J. RODRÍGUEZ, I. FAIRWEATHER, AND C. LANUSSE. 2004. Modificaciones en el metabolismo enantioselectivo de albendazole en Fasciola hepatica resistente a triclabendazole. Proceedings of XXXVI Reunión Anual Sociedad Argentina de Farmacologia Experimental, Argentina.
41. _, AND C. LANUSSE. 2001. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitology Research 87: 275-280.
42. WOLSTENHOLME, A., I. FAIRWEATHER, R. PRICHARD, G. VON SAMSON-HIMMELSTJERNA, AND N. SANGSTER. 2004. Drug resistance in veterinary parasites. Trends in Parasitology 20: 469-476.
43. XU, M., M. MOLENTO, W. BLACKHALL, P. RIBEIRO, P. BEECH, AND R. PRICHARD. 1998. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Molecular and Biochemical Parasitology 91: 327-335.